An Open-Label Positron Emission Tomography (PET) Study to Demonstrate Receptor Occupancy, Safety, Tolerability and Pharmacokinetics of ITI-007 in Stable Schizophrenia Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Mar 2017

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

06 Apr 2016 Results published in the Media Release an Intra-Cellular Therapies media release.
06 Apr 2016 Results presented at the 54th annual meeting of the American College of Neuropsychopharmacology (ACNP), according to an Intra-Cellular Therapies media release.
06 Apr 2016 Data presented at the 5th Biennial Schizophrenia International Research Society (SIRS) Conference 2016, according to an Intra-Cellular Therapies media release.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com